Effect of Empagliflozin on Ambulatory Blood Pressure Monitoring (ABPM)

Not Applicable

• Conditions: Diabetics Mellitus Hypertension

• Registration Number: JPRN-UMIN000022109
• Lead Sponsor: Department of General Internal Medicine, Saitama Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-12-01
• Study Start: 2018-05-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

eGFR<30ml/min/1.73m2 Liver Dysfunction

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change of 24 hour blood pressure

Secondary Outcome Measures

Name	Time	Method
Changes of fast blood glucose and HbA1c Change of renal function